Top 10 mps.org.my Competitors

pharmacy.moh.gov.my

Peta lokasi beralamat di: Lot 36, Jalan Profesor Diraja Ungku Aziz, 46200 Petaling Jaya, Selangor.

mims-cpd.com.my

join mims for free to gain clinical knowledge online. earn cme/cpd credits from courses and live webinars accredited by local medical societies to support your professional development.

prisma.pharmacy.gov.my

prisma is an online application for annual certificate, fully registration, provisional registration, temporary registration and body corporate for pharmacist in malaysia under pharmacy board malaysia.

mycpd2.moh.gov.my

mycpd

mjpharm.org

The outbreak of Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV-2), has infected and killed millions of people worldwide. It has substantially increased the burden on healthcare system. However, the optimal approach to treatment of COVID-19 is uncertain. “Off-label” use of lopinavir/ritonavir (LPV/r) and interferons, particularly interferon beta (IFN-β), were the most suggested at the early stage. Although the United States National Institutes of Health’s (NIH) COVID-19 guidelines do not recommend the use of both medications for the treatment of COVID-19 in hospitalized patients, their roles in patients with non-severe disease are still unclear. Macau, a famous city for tourism, had 46 COVID-19 confirmed cases as of 2020. In this retrospective review, we summarized clinical and laboratory features of 39 COVID-19 patients admitted in the Centro Hospitalar Conde de São Januário (CHCSJ), of whom all did not receive oxygen therapy or ventilatory support during hospitalization. Of note, 12 (30.8%) of them were asymptomatic. The most common symptoms were fever and cough upon admission. They were all treated with LPV/r ± IFN-β-1b plus supportive care. The mean length of hospitalization was 26.6 (SD ± 12.6) days with LPV/r monotherapy, whereas 27.8 (SD ± 10.1) days with LPV/r/IFN-β-1b combination therapy (p=0.65). The percentage of 28-day negative results for polymerase chain reaction (PCR) test were 67.9% (19 of 28) with monotherapy and 63.6% (7 of 11) with combination therapy (p=0.80). No fatal case was reported and all patients discharged successfully. No beneficial clinical outcome was observed with the addition of IFN-β-1b to LPV/r-based therapy. Further studies are warranted to confirm these findings.

otasa.org.za

This is an opportunity to connect, collaborate, and contribute to the future of occupational therapy. Whether you're actively practicing, studying, or supporting the OT profession in another capacity, your voice and presence are valued.

sbot.org.br

Encontre um ortopedista associado à SBOT OU Encontrar Ortopedia e sua saúde

orthoquebec.ca

Association professionnelle des médecins orthopédistes du Québec. Trouvez un médecin dans votre région à l'aide de notre répertoire.